The Worldwide Refractive Surgery Devices Market is Projected to reach USD 331.5 million by 2027, at a CAGR of 9.4%

Refractive Surgery Devices Market Growth, Trends and Report Highlights

According to a new report Global Refractive Surgery Devices Market, published by KBV research, The Global Refractive Surgery Devices Market size is expected to reach $331.5 Million by 2027, rising at a market growth of 9.4% CAGR during the forecast period.

The Astigmatism segment would exhibit the fastest growth rate in the refractive surgery devices market over the forecast years. This segment would fuel the market as there is a rise in the number of cases of astigmatism disorder and improvements in technology. Based on the report by American Optometric Association, approximately everybody is suffering from astigmatism and can be treated with the help of refractive surgery. These aspects are projected to augment the growth of the segment over the forecast period.

The hospitals segment acquired the greatest revenue share in 2020. Ophthalmic refractive surgical devices find their excessive application in hospitals as they offer durable shelf life, thereby anticipated to drive the growth of the segment. In addition, some factors such as enhanced healthcare facilities, favorable reimbursement policies, and a growing number of refractive surgeries are estimated to fuel the hospital segment growth during the forecast years.

North America acquired the highest revenue share of the refractive surgery devices market in 2020. Factors such as the existence of major market players, the accessibility of effective reimbursement policies, and the high incidence of refractive errors are anticipated to drive the growth of the regional market.

Full Report: https://www.kbvresearch.com/refractive-surgery-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Carl Zeiss Meditec AG, Topcon Corporation, Novartis AG, Glaukos Corporation, Johnson & Johnson, Essilorluxottica SA, Bausch Health Companies, Inc., SCHWIND Eye-Tech-Solutions GmbH, NIDEK CO., LTD., and Quantel Medical (Lumibird Group).

Global Refractive Surgery Devices Market Segmentation

By Application

• Astigmatism
• Myopia
• Hyperopia
• Presbyopia, and
• Dry eyes

By Product

• Lasers
• Microkeratome
• Aberrometers and
• Other Products

By End Use

• Government
• Energy
• Defense
• Agriculture & Forestry
• Media & Entertainment
• Civil Engineering & Archaeology
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Carl Zeiss Meditec AG
• Topcon Corporation
• Novartis AG
• Glaukos Corporation
• Johnson & Johnson
• EssilorLuxottica SA
• Bausch Health Companies, Inc.
• SCHWIND Eye-Tech-Solutions GmbH
• NIDEK CO., LTD.
• Quantel Medical (Lumibird Group)

Unique Offerings from KBV Research

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

North America Refractive Surgery Devices Market, Future Scope & Opportunities 2021-2027

Europe Refractive Surgery Devices Market, Size & Growth Forecast 2021-2027

Asia Pacific Refractive Surgery Devices Market, Size, Share & Industry Outlook to 2027

LAMEA Refractive Surgery Devices Market, Growth, Trends and Forecasts 2021-2027